164 related articles for article (PubMed ID: 6229)
1. SKF 525-A inhibition, induction, and 452-nm complex formation.
Buening MK; Franklin MR
Drug Metab Dispos; 1976; 4(3):244-55. PubMed ID: 6229
[TBL] [Abstract][Full Text] [Related]
2. Self-induction by erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450.
Danan G; Descatoire V; Pessayre D
J Pharmacol Exp Ther; 1981 Aug; 218(2):509-14. PubMed ID: 7252850
[TBL] [Abstract][Full Text] [Related]
3. THe formation of cytochrome P-450-metabolic intermediate complexes from amines, in the isolated perfused rat liver.
Gumbrecht JR; Franklin MR
Xenobiotica; 1979 Sep; 9(9):547-54. PubMed ID: 118592
[TBL] [Abstract][Full Text] [Related]
4. Drug metabolism in adult rat hepatocytes in primary monolayer culture.
Guzelian PS; Bissell DM; Meyer UA
Gastroenterology; 1977 Jun; 72(6):1232-9. PubMed ID: 404208
[TBL] [Abstract][Full Text] [Related]
5. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
Jeffery EH; Mannering GJ
Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917
[TBL] [Abstract][Full Text] [Related]
6. Complexation of cytochrome P-450 isozymes in hepatic microsomes from SKF 525-A-induced rats.
Murray M
Arch Biochem Biophys; 1988 May; 262(2):381-8. PubMed ID: 3364973
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of dihalomethanes to carbon monoxide. II. In vitro studies.
Kubic VL; Anders MW
Drug Metab Dispos; 1975; 3(2):104-12. PubMed ID: 236156
[TBL] [Abstract][Full Text] [Related]
8. The effect of certain vitamin deficiencies on hepatic drug metabolism.
Zannoni VG; Sato PH
Fed Proc; 1976 Nov; 35(13):2464-9. PubMed ID: 976490
[TBL] [Abstract][Full Text] [Related]
9. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
Wade AE; Evans JS; Holmes D; Baker MT
Drug Nutr Interact; 1983; 2(2):117-30. PubMed ID: 6432511
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships in the interactions of alkoxymethylenedioxybenzene derivatives with rat hepatic microsomal mixed-function oxidases in vivo.
Murray M; Wilkinson CF; Marcus C; Dubé CE
Mol Pharmacol; 1983 Jul; 24(1):129-36. PubMed ID: 6865922
[TBL] [Abstract][Full Text] [Related]
11. Clotrimazole induction of cytochrome P-450: dose-differentiated isozyme induction.
Ritter JK; Franklin MR
Mol Pharmacol; 1987 Feb; 31(2):135-9. PubMed ID: 3100941
[TBL] [Abstract][Full Text] [Related]
12. Effect of mercuric chloride on microsomal enzyme system in mouse liver.
Abbas-Ali B
Pharmacology; 1980; 21(1):59-63. PubMed ID: 7403256
[TBL] [Abstract][Full Text] [Related]
13. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
Budris DM; Yim GK; Schnell RC
J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A.
Grubb MF; Diamond S; Christ DD
Drug Metab Dispos; 1997 Dec; 25(12):1424-8. PubMed ID: 9394033
[TBL] [Abstract][Full Text] [Related]
15. On the aromatic hydroxylation of amphetamine in rat liver microsomes and perfused liver preparations: effects of long-term administration.
Jonsson J
Acta Pharmacol Toxicol (Copenh); 1977 Apr; 40(4):517-28. PubMed ID: 16430
[TBL] [Abstract][Full Text] [Related]
16. A study of liver microsomal enzymes in rats following propoxur (Baygon) administration.
Nelson DL; Lamb DW; Mihail F
Vet Hum Toxicol; 1984 Aug; 26(4):305-8. PubMed ID: 6464348
[TBL] [Abstract][Full Text] [Related]
17. Effects of clarithromycin and its metabolites on the mixed function oxidase system in hepatic microsomes of rats.
Ohmori S; Ishii I; Kuriya S; Taniguchi T; Rikihisa T; Hirose S; Kanakubo Y; Kitada M
Drug Metab Dispos; 1993; 21(2):358-63. PubMed ID: 8097709
[TBL] [Abstract][Full Text] [Related]
18. [The effect of x-rays on the level, composition and para-nitroanisole-o-demethylase activity of cytochrome P-450 in the liver microsomes of rats].
Deev LI; Akhalaia MIa; Vasilenko OV; Platonov AG; Topchishvili GI
Radiobiologiia; 1984; 24(5):612-5. PubMed ID: 6505149
[TBL] [Abstract][Full Text] [Related]
19. Enhanced rates of cytochrome P450 metabolic-intermediate complex formation from nonmacrolide amines in rifampicin-treated rabbit liver microsomes.
Franklin MR
Drug Metab Dispos; 1995 Dec; 23(12):1379-82. PubMed ID: 8689947
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous immobilization of cytochrome P-450 and glucuronyltransferase for synthesis of drug metabolites.
Lehman JP; Ferrin L; Fenselau C; Yost GS
Drug Metab Dispos; 1981; 9(1):15-8. PubMed ID: 6111425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
